Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Gunthorpe

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Molecular Pharmacology|May 25, 2005
Conservation of functional and pharmacological properties in the distantly related temperature sensors TRVP1 and TRPM8Annette Weil, Stephen E Moore, Nicola J Waite, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 3, 2007
Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraineMagali Peeters, Martin J Gunthorpe, Paul J L M Strijbos, et al.
Epilepsia|January 7, 2012
The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical useCharles H Large, David M Sokal, Astrid Nehlig, et al.
Nature Communications|March 22, 2024
The binding and mechanism of a positive allosteric modulator of Kv3 channelsQiansheng Liang, Gamma Chi, Leonardo Cirqueira, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2004
Discovery of small molecule antagonists of TRPV1Harshad K Rami, Mervyn Thompson, Paul Wyman, et al.
British Journal of Pharmacology|January 20, 2025
Pharmacological profiling of small molecule modulators of the TMEM16A channel and their implications for the control of artery and capillary functionRumaitha Al-Hosni, Emilio Agostinelli, Zeki Ilkan, et al.
Bioorganic & Medicinal Chemistry Letters|April 4, 2006
Discovery of SB-705498: a potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical developmentHarshad K Rami, Mervyn Thompson, Geoffrey Stemp, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 14, 2011
The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: potential for novel treatments for schizophreniaCharles H Large, Silvia Bison, Ilaria Sartori, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 15, 2006
The voltage-gated sodium channel Na(v)1.9 is an effector of peripheral inflammatory pain hypersensitivityFumimasa Amaya, Haibin Wang, Michael Costigan, et al.
Brain and Neuroscience Advances|April 1, 2022
Reducing voltage-dependent potassium channel Kv3.4 levels ameliorates synapse loss in a mouse model of Alzheimer's diseaseJie Yeap, Chaitra Sathyaprakash, Jamie Toombs, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Molecular Pharmacology|May 25, 2005
Conservation of functional and pharmacological properties in the distantly related temperature sensors TRVP1 and TRPM8Annette Weil, Stephen E Moore, Nicola J Waite, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 3, 2007
Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraineMagali Peeters, Martin J Gunthorpe, Paul J L M Strijbos, et al.
Epilepsia|January 7, 2012
The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical useCharles H Large, David M Sokal, Astrid Nehlig, et al.
Nature Communications|March 22, 2024
The binding and mechanism of a positive allosteric modulator of Kv3 channelsQiansheng Liang, Gamma Chi, Leonardo Cirqueira, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2004
Discovery of small molecule antagonists of TRPV1Harshad K Rami, Mervyn Thompson, Paul Wyman, et al.
British Journal of Pharmacology|January 20, 2025
Pharmacological profiling of small molecule modulators of the TMEM16A channel and their implications for the control of artery and capillary functionRumaitha Al-Hosni, Emilio Agostinelli, Zeki Ilkan, et al.
Bioorganic & Medicinal Chemistry Letters|April 4, 2006
Discovery of SB-705498: a potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical developmentHarshad K Rami, Mervyn Thompson, Geoffrey Stemp, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 14, 2011
The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: potential for novel treatments for schizophreniaCharles H Large, Silvia Bison, Ilaria Sartori, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 15, 2006
The voltage-gated sodium channel Na(v)1.9 is an effector of peripheral inflammatory pain hypersensitivityFumimasa Amaya, Haibin Wang, Michael Costigan, et al.
Brain and Neuroscience Advances|April 1, 2022
Reducing voltage-dependent potassium channel Kv3.4 levels ameliorates synapse loss in a mouse model of Alzheimer's diseaseJie Yeap, Chaitra Sathyaprakash, Jamie Toombs, et al.
Pageof 3